SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced completion of treatment for the 10-patient roll-in cohort for the pivotal Phase III CardiAMP Heart Failure Trial. A pre-specified review […]
Tag: Stem therapy
Recent
DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care
BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
Lucia Health Guidelines Initiates Clinical Study Evaluating its Lucia Health Coach Generative AI Agent for Educating and Supporting Patients with Atrial Fibrillation
Popular
- No commented posts yet